Paper2124138
Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer.
Whitford P and 3 others. Br J Cancer, 1990. Cited by 84 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer. Papers, record 2124138. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2124138
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Lymphocytes, Tumor-Infiltrating | Major topic |
| Antigens, Differentiation, T-Lymphocyte | |
| CD4 Antigens | |
| CD8 Antigens | |
| Female | |
| Flow Cytometry | |
| HLA-DR Antigens | |
| Humans |
Source PubMed
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2954917 | Immunohistological analysis of lymphocyte subpopulations infiltrating breast carcinomas and benign lesions. | Int J Cancer | 1987 | https://conductscience.org/library/papers/2954917 | PubMed |
| 2 | 6268135 | Lymphocytes infiltrating human breast cancers lack K-cell activity and show low levels of NK-cell activity. | Br J Cancer | 1981 | https://conductscience.org/library/papers/6268135 | PubMed |
| 3 | 6976792 | Specific and non-specific lymphocyte cytotoxicity in colon carcinoma. | Br J Cancer | 1981 | https://conductscience.org/library/papers/6976792 | PubMed |
| 4 | 2783889 | Characterization of T-lymphocyte subpopulations infiltrating primary breast cancer. | Cancer Immunol Immunother | 1989 | https://conductscience.org/library/papers/2783889 | PubMed |
| 5 | 3032398 | Antigenic phenotype of the lymphocytic component of medullary carcinoma of the breast. | Cancer | 1987 | https://conductscience.org/library/papers/3032398 | PubMed |
| 6 | 3257161 | Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activity. | Cancer Res | 1988 | https://conductscience.org/library/papers/3257161 | PubMed |
| 7 | 2679456 | Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients. | Ann Surg | 1989 | https://conductscience.org/library/papers/2679456 | PubMed |
| 8 | 2578284 | Heterogeneous expression of cell-surface antigens in normal epithelia and their tumours, revealed by monoclonal antibodies. | Br J Cancer | 1985 | https://conductscience.org/library/papers/2578284 | PubMed |
| 9 | 6193308 | Immunohistologic characterization of major histocompatibility antigens and inflammatory cellular infiltrate in human breast cancer. | J Natl Cancer Inst | 1983 | https://conductscience.org/library/papers/6193308 | PubMed |
| 10 | 3031660 | Interleukin 2 binding molecule distinct from the Tac protein: analysis of its role in formation of high-affinity receptors. | Proc Natl Acad Sci U S A | 1987 | https://conductscience.org/library/papers/3031660 | PubMed |
| 11 | 3086239 | Separation, phenotyping and limiting dilution analysis of T-lymphocytes infiltrating human solid tumors. | Int J Cancer | 1986 | https://conductscience.org/library/papers/3086239 | PubMed |
| 12 | 6365132 | Characterisation of breast cancer infiltrates using monoclonal antibodies to human leucocyte antigens. | Br J Cancer | 1984 | https://conductscience.org/library/papers/6365132 | PubMed |
| 13 | 3315186 | Long-term interleukin 2-dependent growth and cytotoxic activity of tumor-infiltrating lymphocytes from human squamous cell carcinomas of the head and neck. | Cancer Res | 1987 | https://conductscience.org/library/papers/3315186 | PubMed |
| 14 | 2688708 | The interleukin 2 receptor. | Annu Rev Cell Biol | 1989 | https://conductscience.org/library/papers/2688708 | PubMed |
| 15 | 3264384 | Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report. | N Engl J Med | 1988 | https://conductscience.org/library/papers/3264384 | PubMed |
| 16 | 2972629 | Proliferative and cytolytic potentials of purified human tumor-infiltrating T lymphocytes. Impaired response to mitogen-driven stimulation despite T-cell receptor expression. | Int J Cancer | 1988 | https://conductscience.org/library/papers/2972629 | PubMed |
| 17 | 6365133 | Expression of major histocompatibility antigens and leucocyte infiltration in benign and malignant human breast disease. | Br J Cancer | 1984 | https://conductscience.org/library/papers/6365133 | PubMed |
| 18 | 2989190 | Mononuclear cells infiltrating human mammary carcinomas: immunohistochemical analysis with monoclonal antibodies. | Int J Cancer | 1985 | https://conductscience.org/library/papers/2989190 | PubMed |
| 19 | 3099289 | Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex. | Proc Natl Acad Sci U S A | 1986 | https://conductscience.org/library/papers/3099289 | PubMed |
| 21 | 3435700 | Immunophenotype of the lymphoid cell infiltrates in breast carcinomas of low oestrogen receptor content. | Br J Cancer | 1987 | https://conductscience.org/library/papers/3435700 | PubMed |
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 84 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40593750 | Evolutionary regulation of human Fas ligand (CD95L) by plasmin in solid cancer immunotherapy. | Nat Commun | 2025 | https://conductscience.org/library/papers/40593750 | PubMed |
| 36010863 | Identification of Immune Cell Components in Breast Tissues by a Multiparametric Flow Cytometry Approach. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36010863 | PubMed |
| 35577913 | Immunological profiles of the breast cancer microenvironment represented by tumor-infiltrating lymphocytes and PD-L1 expression. | Sci Rep | 2022 | https://conductscience.org/library/papers/35577913 | PubMed |
| 35437570 | The Landscape of Immune Microenvironments in Racially Diverse Breast Cancer Patients. | Cancer Epidemiol Biomarkers Prev | 2022 | https://conductscience.org/library/papers/35437570 | PubMed |
| 33704737 | Immunotyping and Quantification of Melanoma Tumor-Infiltrating Lymphocytes. | Methods Mol Biol | 2021 | https://conductscience.org/library/papers/33704737 | PubMed |
| 33587338 | Unexpected PD-L1 immune evasion mechanism in TNBC, ovarian, and other solid tumors by DR5 agonist antibodies. | EMBO Mol Med | 2021 | https://conductscience.org/library/papers/33587338 | PubMed |
| 31408436 | Tumor infiltrating B-cells signal functional humoral immune responses in breast cancer. | JCI Insight | 2019 | https://conductscience.org/library/papers/31408436 | PubMed |
| 28121628 | Combined evaluation of the FAS cell surface death receptor and CD8+ tumor infiltrating lymphocytes as a prognostic biomarker in breast cancer. | Oncotarget | 2017 | https://conductscience.org/library/papers/28121628 | PubMed |
| 27473163 | Differential tumor infiltration by T-cells characterizes intrinsic molecular subtypes in breast cancer. | J Transl Med | 2016 | https://conductscience.org/library/papers/27473163 | PubMed |
| 23336253 | The crosstalk: Tumor-infiltrating lymphocytes rich in regulatory T cells suppressed cancer-associated fibroblasts. | Acta Oncol | 2013 | https://conductscience.org/library/papers/23336253 | PubMed |
| 23071686 | CD49f is an efficient marker of monolayer- and spheroid colony-forming cells of the benign and malignant human prostate. | PLoS One | 2012 | https://conductscience.org/library/papers/23071686 | PubMed |
| 22420471 | CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer. | Breast Cancer Res | 2012 | https://conductscience.org/library/papers/22420471 | PubMed |
| 21666707 | Persistence of tumor-infiltrating CD8 T cells is tumor-dependent but antigen-independent. | Cell Mol Immunol | 2011 | https://conductscience.org/library/papers/21666707 | PubMed |
| 15999153 | Tumor-infiltrating B cell immunoglobulin variable region gene usage in invasive ductal breast carcinoma. | Pathol Oncol Res | 2005 | https://conductscience.org/library/papers/15999153 | PubMed |
| 11742495 | EBAG9/RCAS1 in human breast carcinoma: a possible factor in endocrine-immune interactions. | Br J Cancer | 2001 | https://conductscience.org/library/papers/11742495 | PubMed |
| 11250688 | Gene therapy for carcinoma of the breast: Genetic immunotherapy. | Breast Cancer Res | 2000 | https://conductscience.org/library/papers/11250688 | PubMed |
| 10606960 | Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis. | Clin Exp Immunol | 2000 | https://conductscience.org/library/papers/10606960 | PubMed |
| 9192989 | High incidence of interleukin 10 mRNA but not interleukin 2 mRNA detected in human breast tumours. | Br J Cancer | 1997 | https://conductscience.org/library/papers/9192989 | PubMed |
| 8855979 | Clonal and functional analysis for the augmentation of tumour-infiltrating lymphocytes by interleukin 4. | Br J Cancer | 1996 | https://conductscience.org/library/papers/8855979 | PubMed |
| 8646519 | In situ cytokine production by breast cancer tumor-infiltrating lymphocytes. | Ann Surg Oncol | 1996 | https://conductscience.org/library/papers/8646519 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| EREG | 2069 | PubTator's text mining | https://conductscience.org/library/genes/2069 | NCBI Gene |
| IL2RA | 3559 | PubTator's text mining | https://conductscience.org/library/genes/3559 | NCBI Gene |
| IL2RB | 3560 | PubTator's text mining | https://conductscience.org/library/genes/3560 | NCBI Gene |
| TFRC | 7037 | PubTator's text mining | https://conductscience.org/library/genes/7037 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2124138
GET https://conductscience.org/api/papers/v1/2124138/references?page=2